Randomised Controlled Trial of Alemtuzumab and Tacrolimus Monotherapy with Daclizumab, Tacrolimus and Mycophenolate Mofetil in Renal Transplantation.

被引：0
|
作者：
Chan, K. [1 ]
Galliford, J. [1 ]
Goodall, D. [1 ]
Charif, R. [1 ]
Dorling, A. [1 ]
Warrens, A. [1 ]
Hakim, N. [1 ]
Papalois, V. [1 ]
Taube, D. [1 ]
McLean, A. [1 ]
机构：
[1] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, W London Renal & Transplant Ctr, Kidney & Transplant Inst, London, England
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2009年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：282 / 282
页数：1
相关论文
共 50 条
  • [31] Relationship of Tacrolimus Exposure and Mycophenolate Mofetil Dose With Renal Function After Renal Transplantation
    Ekberg, Henrik
    van Gelder, Teun
    Kaplan, Bruce
    Bernasconi, Corrado
    TRANSPLANTATION, 2011, 92 (01) : 82 - 87
  • [32] Racial differences in clinical outcome using tacrolimus and mycophenolate mofetil immunosuppression in heart transplantation.
    Mehra, MR
    Uber, PA
    Scott, RL
    Prasad, AK
    Park, MH
    TRANSPLANTATION, 2000, 69 (08) : S292 - S292
  • [33] A Prospective Randomized Open Study in Liver Transplant Recipients: Daclizumab, Mycophenolate Mofetil, and Tacrolimus Versus Tacrolimus and Steroids
    Otero, Alejandro
    Varo, Evaristo
    Ortiz de Urbina, Jorge
    Martin-Vivaldi, Rafael
    Cuervas-Mons, Valentin
    Gonzalez-Pinto, Ignacio
    Rimola, Antoni
    Bernardos, Angel
    Otero, Santiago
    Maldonado, Jorge
    Herrero, Jose I.
    Barrao, Elena
    Dominguez-Granados, Rosa
    LIVER TRANSPLANTATION, 2009, 15 (11) : 1542 - 1552
  • [34] Randomized comparative trial of mizoribine versus mycophenolate mofetil in combination with tacrolimus for living donor renal transplantation
    Takahara, Shiro
    Takahashi, Kota
    Akiyama, Takahiro
    Uchida, Kazuharu
    Tanabe, Kazunari
    Amada, Noritoshi
    Toma, Hiroshi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2013, 17 (06) : 899 - 904
  • [35] Tacrolimus and mycophenolate mofetil regimens in transplantation - Benefits and pitfalls
    Ciancio, G
    Burke, GW
    Roth, D
    Miller, J
    BIODRUGS, 1999, 11 (06) : 395 - 407
  • [36] The use of tacrolimus and mycophenolate mofetil after cardiac transplantation
    Taylor, DO
    CURRENT OPINION IN CARDIOLOGY, 1997, 12 (02) : 161 - 165
  • [37] The use of daclizumab, tacrolimus and mycophenolate mofetil in African-American and Hispanic first renal transplant recipients
    Ciancio, G
    Burke, GW
    Suzart, K
    Mattiazzi, A
    Vaidya, A
    Roth, D
    Kupin, W
    Rosen, A
    Johnson, N
    Miller, J
    AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (08) : 1010 - 1016
  • [38] EVALUATING THE EFFICACY AND SAFETY OF DACLIZUMAB, TACROLIMUS, MYCOPHENOLATE AND CORTICOSTEROIDS IMMUNOSUPPRESSIVE REGIMEN IN COMPARISON TO CURRENT STANDART IMMUNOSUPPRESSION (TACROLIMUS, MYCOPHENOLATE AND CORTICOSTEROIDS) IN RENAL TRANSPLANTATION
    Kuman, Milan
    Studenik, Pavel
    Mejzlik, Vladimir
    Ondrasek, Jiri
    Nemec, Petr
    TRANSPLANT INTERNATIONAL, 2009, 22 : 232 - 232
  • [39] Prospective randomize trial of tacrolimus and steroid vs tacrolimus steroid and mycophenolate mofetil in primary adult liver transplantation
    Jain, A
    Hamad, I
    Kashyap, R
    Rishi, SN
    Kramer, D
    Rakela, J
    Fung, JJ
    HEPATOLOGY, 1998, 28 (04) : 241A - 241A
  • [40] Results of a triple induction regime with tacrolimus, mycophenolate mofetil, and prednisone in renal transplantation
    Facundo, C
    Diaz, JM
    Guirado, L
    Duran, F
    Herreros, MA
    Diaz, M
    Sola, R
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (01) : 98 - 98
12345